scispace - formally typeset
M

Maxine S. Jochelson

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  139
Citations -  5270

Maxine S. Jochelson is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Breast cancer & Mammography. The author has an hindex of 37, co-authored 117 publications receiving 4160 citations. Previous affiliations of Maxine S. Jochelson include Cornell University & Cedars-Sinai Medical Center.

Papers
More filters
Book ChapterDOI

Use of Contrast-Enhanced Mammography in Breast Cancer Screening

TL;DR: In women at greater than 20% risk for developing cancer, yearly MRI in addition to mammography is the accepted standard of care, however, MRI is expensive and not consistently available enough to perform routine screening in a larger population of women including those at intermediate risk or those with dense breasts.
Journal ArticleDOI

Stereotactic breast biopsy efficiency: Does a pre-biopsy grid image help?

TL;DR: Grid imaging increases images obtained but decreases retargeting and biopsy table time at the expense of mammogram room/technologist time to obtain the grid image, which has limited usefulness and should be used judiciously in cases where prone positioning is challenging to patients.
Journal Article

The treated thorax.

TL;DR: The radiographic and clinical aspects of how the thorax responds to treatment are reviewed in Hodgkin's disease and non-Hodgkin's lymphoma.
Journal ArticleDOI

Can Follow-up be Avoided for Probably Benign US Masses with No Enhancement on MRI?

TL;DR: The incorporation of MRI, when ordered by the referring physician, may decrease unnecessary follow-up imaging and/or biopsy if the initial US BI-RADS assessment and management recommendation were to be retrospectively updated.
Journal ArticleDOI

Does every woman presenting with malignant calcifications require a post lumpectomy mammogram

TL;DR: PLM plays an important role in the evaluation of patients undergoing breast conservation for breast cancer presenting with microcalcifications, and Residual malignancy was detected on positive PLM in 6% of patients with negative margins.